CD39/CD73/A2AR pathway and cancer immunotherapy

C Xia, S Yin, KKW To, L Fu - Molecular cancer, 2023 - Springer
Cancer development is closely associated with immunosuppressive tumor
microenvironment (TME) that attenuates antitumor immune responses and promotes tumor …

Next generation of immune checkpoint inhibitors and beyond

JA Marin-Acevedo, EMO Kimbrough, Y Lou - Journal of hematology & …, 2021 - Springer
The immune system is the core defense against cancer development and progression.
Failure of the immune system to recognize and eliminate malignant cells plays an important …

Metabolism of immune cells in cancer

RD Leone, JD Powell - Nature reviews cancer, 2020 - nature.com
Through the successes of checkpoint blockade and adoptive cellular therapy,
immunotherapy has become an established treatment modality for cancer. Cellular …

Cervical cancer immunotherapy: facts and hopes

L Ferrall, KY Lin, RBS Roden, CF Hung, TC Wu - Clinical Cancer Research, 2021 - AACR
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …

Next generation of immune checkpoint therapy in cancer: new developments and challenges

JA Marin-Acevedo, B Dholaria, AE Soyano… - Journal of hematology & …, 2018 - Springer
Immune checkpoints consist of inhibitory and stimulatory pathways that maintain self-
tolerance and assist with immune response. In cancer, immune checkpoint pathways are …

Targets of immune escape mechanisms in cancer: basis for development and evolution of cancer immune checkpoint inhibitors

S Dutta, A Ganguly, K Chatterjee, S Spada… - Biology, 2023 - mdpi.com
Simple Summary The tumor immune escape mechanisms are key factors in cancer
progression and metastasis. They are an undeniable hurdle for successful cancer treatment …

Targeting neoantigens to augment antitumour immunity

M Yarchoan, BA Johnson III, ER Lutz… - Nature Reviews …, 2017 - nature.com
The past decade of cancer research has been marked by a growing appreciation of the role
of immunity in cancer. Mutations in the tumour genome can cause tumours to express …

The ectonucleotidases CD 39 and CD 73: novel checkpoint inhibitor targets

B Allard, MS Longhi, SC Robson… - Immunological …, 2017 - Wiley Online Library
Cancers are able to grow by subverting immune suppressive pathways, to prevent the
malignant cells as being recognized as dangerous or foreign. This mechanism prevents the …

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy

L Giuffrida, K Sek, MA Henderson, J Lai… - Nature …, 2021 - nature.com
Adenosine is an immunosuppressive factor that limits anti-tumor immunity through the
suppression of multiple immune subsets including T cells via activation of the adenosine …

When worlds collide: Th17 and Treg cells in cancer and autoimmunity

HM Knochelmann, CJ Dwyer, SR Bailey… - Cellular & molecular …, 2018 - nature.com
The balance between Th17 cells and regulatory T cells (Tregs) has emerged as a prominent
factor in regulating autoimmunity and cancer. Th17 cells are vital for host defense against …